Aortic, Stenosis and Tricuspid - Cardiovascular Update

Eagleâ€™s Eye View: Sacubitril/Valsartan in Decompensated Heart Failure; Discordant Aortic Stenosis and Transcatheter Treatment of Tricuspid Valve Regurgitation

American College of Cardiology

MARCH 27, 2024

Eagle looks at sacubitril/valsartan in patients hospitalized with decompensated heart failure, then examines the prevalence and outcomes of patients with discordant high gradient aortic stenosis.

Heart Failure

Heart Failure Stenosis Aortic Tricuspid

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

DAIC

APRIL 2, 2024

Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S million people in the U.S. are estimated to be affected. the Roger L.

Tricuspid

Tricuspid Heart Valves Quality of Life Open-Heart Surgery

Progression of aortic stenosis after an acute myocardial infarction

Open Heart

JUNE 21, 2022

Background Myocardial infarction (MI) has been shown to induce fibrotic remodelling of the mitral and tricuspid valves. It is unknown whether MI also induces pathological remodelling of the aortic valve and alters aortic stenosis (AS) progression. vs –0.04±0.04 cm 2 /m 2 /year; p=0.004).

Myocardial Infarction

Myocardial Infarction Aortic Aortic valve Stenosis

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

DAIC

FEBRUARY 15, 2024

Food and Drug Administration ( FDA ) confirmed 13 to 1, with 0 abstention that the benefits of Abbott's TriClip™ transcatheter edge-to-edge repair (TEER) system outweighed the risks for the treatment of people with tricuspid regurgitation (TR). On the final question of the benefit of TriClip versus the risk, the vote was 13 to 1 in favor.

Tricuspid

Tricuspid Heart Valves Quality of Life Bicuspid/Mitral

Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement

Open Heart

OCTOBER 19, 2022

Objective A novel artificial intelligence-based phenotyping approach to stratify patients with severe aortic stenosis (AS) prior to transcatheter aortic valve replacement (TAVR) has been proposed, based on echocardiographic and haemodynamic data. ±15.8 ±15.1 mm Hg, p value: 0.0079). to 84.7%) and 74.6% (95% CI 65.9%

Aortic valve

Aortic valve Aortic Stenosis TAVR

Quantitative fluid overload in severe aortic stenosis refines cardiac damage and associates with worse outcomes

European Journal of Heart Failure

OCTOBER 30, 2023

Assessment of fluid overload identifies aortic stenosis (AS) patients at high risk and treatment of fluid overload may potentially improve the post-interventional clinical course. TAVI, transcatheter aortic valve implantation. FO by BIS was defined as ≥1.0 L L = euvolaemia).

Stenosis

Stenosis Aortic Aortic valve Outcomes

Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left?sided valvular heart disease in Europe. Insights from the ESC?EORP Valvular Heart Disease II survey

European Journal of Heart Failure

FEBRUARY 19, 2024

Tricuspid regurgitation (TR): frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. ESC-EORP, European Society of Cardiology-EURObservational Research Programme; TV, tricuspid valve.

Tricuspid

Tricuspid Heart Disease Bicuspid/Mitral Heart Valves

Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation

Heart BMJ

MARCH 22, 2024

Objectives This study aimed to evaluate the prognostic value of coronary microvascular dysfunction (CMD) at long term after transcatheter aortic valve implantation (TAVI) and to explore its relationship with extravalvular cardiac damage (EVCD).

Aortic valve

Aortic valve Aortic Tricuspid Heart Failure

SAVR’s Value in the TAVR Era

CardiacWire

JANUARY 31, 2024

Procedure trends certainly suggest that we’ve entered the TAVR era, but a pair of new studies show that surgical aortic valve replacement (SAVR) is a far better option for many younger and healthier patients who are increasingly seen as TAVR candidates. Much of these SAVR declines occurred in patients with tricuspid aortic valves (from 84.5%

TAVR

TAVR Aortic valve Bicuspid/Mitral Aortic

Cardiovascular Research Foundation, CRF, Introduces New York Valves: The Structural Heart Summit

DAIC

APRIL 5, 2024

Transcatheter valve therapy has evolved from a novel treatment for the sickest patients to become the standard of care for many with aortic stenosis. The rapid adoption of transcatheter mitral and tricuspid therapies has also transformed the treatment landscape, expanding options for patients with structural heart disease.

Research

Research Heart Disease Best Practices Education

CRG Introduces New York Valves: The Structural Heart Summit

DAIC

APRIL 5, 2024

Transcatheter valve therapy has evolved from a novel treatment for the sickest patients to become the standard of care for many with aortic stenosis. The rapid adoption of transcatheter mitral and tricuspid therapies has also transformed the treatment landscape, expanding options for patients with structural heart disease.

Heart Disease

Heart Disease Best Practices Education Tricuspid

Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Ascending aortic diameter was the single predictor of 1-year mortality in type 0 bicuspid patients (hazard ratio, 1.59 [95% CI, 1.03–2.44];P=0.035). Poverall=0.522; 1 year: 10% versus 2.3%

Aortic valve

Aortic valve Bicuspid/Mitral Aortic Tricuspid

AISAP’s CARDIO AI-powered Diagnostic Assessment Software Receives FDA Clearance

DAIC

AUGUST 27, 2024

Standalone performance for significant major valve disease pathology (aortic stenosis and regurgitation and mitral and tricuspid regurgitation) had a 93 percent sensitivity and 93 percent specificity.

Ultrasound

Ultrasound Tricuspid Bicuspid/Mitral Aortic

Predictors of outcome in patients with moderate mixed aortic valve disease

Heart BMJ

APRIL 25, 2024

Objectives Grading the severity of moderate mixed aortic stenosis and regurgitation (MAVD) is challenging and the disease poorly understood. Methods Moderate MAVD was defined as coexisting moderate aortic stenosis (aortic valve area (AVA) 1.0–1.5 –1.5 –0.6 –1.5 –0.6 to 0.99; p=0.007).

Aortic valve

Aortic valve Aortic Outcomes Myocardial Infarction

Transcatheter versus surgical valve replacement in patients with bicuspid aortic valves: an updated meta-analysis

The British Journal of Cardiology

FEBRUARY 20, 2024

Patients with bicuspid aortic valves (BAV) are predisposed to the development of aortic stenosis. We performed a pairwise meta-analysis, comparing the efficacy of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in patients with BAV. to 4.58, p=0.04).

Aortic valve

Aortic valve Bicuspid/Mitral Aortic TAVR

Basics of Echocardiography

All About Cardiovascular System and Disorders

APRIL 4, 2024

Usual structures imaged in this view are the right ventricular free wall and outflow region, interventricular septum, aorta, and aortic valve, left ventricular outflow tract, anterior and posterior mitral leaflets, left ventricular cavity, posterior wall of left ventricle and left atrium. Apical four chamber view is illustrated here.

Bicuspid/Mitral

Bicuspid/Mitral Echocardiogram Tricuspid Aortic

Computed tomography calcium scoring in aortic stenosis: bicuspid versus tricuspid morphology

Heart BMJ

MARCH 22, 2024

Objective CT aortic valve calcium score (AVC score ) and density (AVC density ) thresholds have been recommended for aortic stenosis (AS) severity assessment in tricuspid aortic valve (TAV). We aimed to compare AVC score and AVC density in bicuspid aortic valve (BAV) versus TAV.

Bicuspid/Mitral

Bicuspid/Mitral Tricuspid Aortic Stenosis

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Eagleâ€™s Eye View: Sacubitril/Valsartan in Decompensated Heart Failure; Discordant Aortic Stenosis and Transcatheter Treatment of Tricuspid Valve Regurgitation

Abbott Announces FDA Approval of First-of-its-kind Device to Repair Leaky Tricuspid Heart Valve, TriClip

Progression of aortic stenosis after an acute myocardial infarction

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

Artificial intelligence-enabled phenotyping of patients with severe aortic stenosis: on the recovery of extra-aortic valve cardiac damage after transcatheter aortic valve replacement

Quantitative fluid overload in severe aortic stenosis refines cardiac damage and associates with worse outcomes

Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left?sided valvular heart disease in Europe. Insights from the ESC?EORP Valvular Heart Disease II survey

Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation

SAVR’s Value in the TAVR Era

Cardiovascular Research Foundation, CRF, Introduces New York Valves: The Structural Heart Summit

CRG Introduces New York Valves: The Structural Heart Summit

Outcomes Following Transcatheter Aortic Valve Replacement for Aortic Stenosis in Patients With Type 0 Bicuspid, Type 1 Bicuspid, and Tricuspid Aortic Valves

AISAP’s CARDIO AI-powered Diagnostic Assessment Software Receives FDA Clearance

Predictors of outcome in patients with moderate mixed aortic valve disease

Transcatheter versus surgical valve replacement in patients with bicuspid aortic valves: an updated meta-analysis

Basics of Echocardiography

Computed tomography calcium scoring in aortic stenosis: bicuspid versus tricuspid morphology

Published Research

Published Research

Stay Connected